Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Best Practice & Research. Clinical Haematology
|
October 20, 2001
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
D Grimwade
Current Topics in Microbiology and Immunology
|
January 1, 1997
Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia
D Grimwade, E Solomon
Leukemia
|
January 23, 2004
Acute promyelocytic leukemia: where does it stem from?
D Grimwade, T Enver
Leukemia
|
October 3, 2002
Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia
D Grimwade, F Lo Coco
Biochemical and Biophysical Research Communications
|
February 22, 2001
Repression of CD2 gene expression is mediated by an AP-2 related factor
S V Outram, D Grimwade, T Crompton
European Journal of Cancer & Clinical Oncology
|
November 1, 1985
Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma
B C Baguley, C D Grimwade, A R Kernohan
British Journal of Haematology
|
August 1, 1997
Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid
G Evans, D Grimwade, H G Prentice, et al.
British Journal of Haematology
|
March 1, 1997
Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukaemia. MRC Adult Leukaemia Working Party
D Rees, D Grimwade, S Langabeer, et al.
British Journal of Haematology
|
March 6, 1998
Acute promyelocytic leukaemia with t(11;17)(q23;q12-21) and a good initial response to prolonged ATRA and combination chemotherapy
D J Culligan, D Stevenson, Y L Chee, et al.
British Journal of Haematology
|
July 11, 2000
Screening for mutations of Bcl10 in leukaemia
D Grimwade, M Q Du, S Langabeer, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Best Practice & Research. Clinical Haematology
|
October 20, 2001
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
D Grimwade
Current Topics in Microbiology and Immunology
|
January 1, 1997
Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia
D Grimwade, E Solomon
Leukemia
|
January 23, 2004
Acute promyelocytic leukemia: where does it stem from?
D Grimwade, T Enver
Leukemia
|
October 3, 2002
Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia
D Grimwade, F Lo Coco
Biochemical and Biophysical Research Communications
|
February 22, 2001
Repression of CD2 gene expression is mediated by an AP-2 related factor
S V Outram, D Grimwade, T Crompton
European Journal of Cancer & Clinical Oncology
|
November 1, 1985
Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma
B C Baguley, C D Grimwade, A R Kernohan
British Journal of Haematology
|
August 1, 1997
Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid
G Evans, D Grimwade, H G Prentice, et al.
British Journal of Haematology
|
March 1, 1997
Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukaemia. MRC Adult Leukaemia Working Party
D Rees, D Grimwade, S Langabeer, et al.
British Journal of Haematology
|
March 6, 1998
Acute promyelocytic leukaemia with t(11;17)(q23;q12-21) and a good initial response to prolonged ATRA and combination chemotherapy
D J Culligan, D Stevenson, Y L Chee, et al.
British Journal of Haematology
|
July 11, 2000
Screening for mutations of Bcl10 in leukaemia
D Grimwade, M Q Du, S Langabeer, et al.
Page
of 5